![Mark Parry-Billings](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Parry-Billings
Président chez
SYNAIRGEN PLC
Profil
Mark Parry-Billings is Executive Chairman at Synairgen Plc starting in 2025.
Former roles include Chief Executive Officer at Topigen Pharmaceuticals, Inc. from 2007 to 2010, Chairman at Zymenex A, Director at Innovata Biomed Ltd., Director at pSiMedica Ltd., Principal at Schering Health Care Ltd., and Head-Corporate Drug Development at CHIESI Farmaceutici SpA. Education includes a doctorate from the University of Oxford.
Postes actifs de Mark Parry-Billings
| Sociétés | Poste | Début |
|---|---|---|
| SYNAIRGEN PLC | Président | 10/10/2024 |
Anciens postes connus de Mark Parry-Billings
| Sociétés | Poste | Fin |
|---|---|---|
Topigen Pharmaceuticals, Inc.
 Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Directeur Général | 01/01/2010 |
CHIESI Farmaceutici SpA
 CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Corporate Officer/Principal | - |
Zymenex A/S
 Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Président | - |
Schering Health Care Ltd. | Corporate Officer/Principal | - |
Innovata Biomed Ltd.
 Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Directeur/Membre du Conseil | - |
Formation de Mark Parry-Billings
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
11
Relations au 1er degré
8
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 8 |
|---|---|
Schering Health Care Ltd. | |
Synairgen Plc
 Synairgen Plc Pharmaceuticals: MajorHealth Technology Discovers and develops drugs for respiratory disorders | Health Technology |
University of Oxford
 University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CHIESI Farmaceutici SpA
CHIESI Farmaceutici SpA Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops and markets respiratory health, rare diseases and specialty care products | Health Technology |
Innovata Biomed Ltd.
Innovata Biomed Ltd. Miscellaneous Commercial ServicesCommercial Services Engages in the research, development, and commercialization of respiratory drug delivery technologies | Commercial Services |
pSiMedica Ltd.
 pSiMedica Ltd. Miscellaneous Commercial ServicesCommercial Services Researches and develops nanostructured porous silicon | Commercial Services |
Zymenex A/S
Zymenex A/S BiotechnologyHealth Technology Engages in the research and development of therapeutics for life threatening diseases | Health Technology |
Topigen Pharmaceuticals, Inc.
Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases | Health Technology |
